Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Overview
- Limited proteolysis vs. degradation
- Regulation of proteolytic activity (1)
- Regulation of proteolytic activity (2)
- Apoptotic pathway
- Caspase structure (1)
- Caspase structure (2)
- Caspase structure - the active site
- Caspase structure - zooming in the active site
- Caspase zymogen activation
- Monomer/dimer status of caspase zymogens
- Initiator and executioner caspases
- Natural caspase inhibitors
- CrmA
- Selectivity of CrmA
- p35
- Selectivity of p35
- p35 docks into active site of caspases
- CrmA and caspases active site
- Viral "suicide" caspase inhibitors
- IAPs - the endogenous caspase regulators
- Human IAPs (BIRC 1-8)
- Some other IAPs
- Mouse IAPs knockout phenotypes
- Multiple proposed IAP functions
- The BIR domain (1)
- The BIR domain (2)
- IAPs as caspase inhibitors - XIAP, the paradigm
- Domain organization of XIAP
- Caspase 3/BIR2 complex
- Structure of caspase 3/DEVD-CHO
- Structure of the caspase 3/BIR2 complex
- Inhibitor footprints and the role of the 381 loop
- Caspase-3 bound state
- Caspase-3 free state
- Two site interaction hypothesis
- BIR2 mechanism
- Comparison of XIAP-BIR complexes
- BIR3 mechanism
- XIAP inhibition of caspases
- Caspase activation vs. IAP derepression
- The SMAC groove...competition of IBMs
- IBMs
- SMAC mechanism - caspase 9/BIR3
- BIR domain topology
- BIR2 domain comparisons - the SMAC groove
- BIR2 domain comparisons - the N-terminal linker
- BIR3 domain comparisons - the SMAC groove
- BIR2 domain comparisons - the C-terminal helix
- Variations in N-terminal linker or C-terminal helix
- Human IAPs (BIRC 1-8)
- What about the other 7 human IAPs?
- Acknowledgements
- Representative reviews
Topics Covered
- Apoptosis
- Proteolytic mechanisms
- Caspases
- Activation mechanisms
- Natural caspase inhibitors
- Viral inhibitors
- IAPs
- Inhibitory mechanisms
- IAP antagonists
- Theory of activating apoptosis by de-repression of caspase inhibition
Talk Citation
Salvesen, G. (2007, October 1). Natural caspase inhibitors [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/CXLK6356.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Guy Salvesen has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.